What's new? Log in Free sign up

4D Pharma (LBPWQ)

Company Profile

Company profile

Ticker

LBPWQ

Exchange

Website

www.4dpharmaplc.com/

CEO

Duncan Peyton

Incorporated

Location

Fiscal year end

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Johnson & Johnson • Merck & Co. • Alabama Power • Mississippi Power • Teva Pharmaceutical Industries Limited • Entergy Arkansas • Abbott Laboratories • Eli Lilly and • Bristol-Myers Squibb ...

SEC CIK

Corporate docs

Articles of Incorporation & Bylaws

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

LBPWQ stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

Notice of Cancellation of Admission to Trading on Aim

Current report (foreign)

Current report (foreign)

4D pharma Announces an Update on Administration and Suspension of Trading

4D pharma’s Blautix® Phase II Clinical Trial Results Published in Alimentary Pharmacology & Therapeutics

Current report (foreign)

Current report (foreign)

Delay to publication of Interim Results

Current report (foreign)

Delisting of Securities of 4D pharma plc from The Nasdaq Stock Market

Latest ownership filings

Oliveira Steven Michael

Stevenson Alexander

Oliveira Steven Michael

Merck & Co., Inc.

Oliveira Steven Michael

Financial summary

Financial statements Chart LBPWQ financial data

Quarter (USD)	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from 4D Pharma earnings reports.

Institutional ownership, Q3 2022

LBPWQ institutional ownership history Ownership history

11.7% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	3	10	-70.0%
Opened positions	0	1	EXIT
Closed positions	7	3	+133.3%
Increased positions	0	1	EXIT
Reduced positions	0	3	EXIT

13F shares	Current	Prev Q	Change
Total value	94.87 mm	95.30 mm	-0.5%
Total shares	21.06 mm	21.32 mm	-1.2%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
MRK Merck & Co.	12.15 mm	$66.19 mm	0.0%
Oliveira Steven Michael	8.91 mm	$28.68 mm	0.0%
Tower Research Capital	4.64 k	$0.00	0.0%

Largest transactions	Shares	Bought/sold	Change
Ruffer	0.00	-195.95 k	EXIT
Citadel Advisors	0.00	-28.17 k	EXIT
Capstone Investment Advisors	0.00	-15.20 k	EXIT
Wolverine Asset Management	0.00	-8.06 k	EXIT
Advisor	0.00	-4.80 k	EXIT
MS Morgan Stanley	0.00	-4.36 k	EXIT
Credit Suisse	0.00	-1.64 k	EXIT
MRK Merck & Co.	12.15 mm	0.00	0.0%
Oliveira Steven Michael	8.91 mm	0.00	0.0%
Tower Research Capital	4.64 k	0.00	0.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.